Advertisement

Adenosine Injection

[29 January 2016]

Products Affected - Description

Use in Paroxysmal Supraventricular Tachycardia
Adenosine intravenous injection, West-Ward
3 mg/mL, 2 mL vial, 10 count (NDC 00641-6113-10)

Reason for the Shortage

  • Astellas discontinued Adenoscan in April 2015. Adenoscan is used for diagnostic purposes as an adjunct to thallium-201 myocardial perfusion scintigraphy. Adenocard and generic adenosine products are labeled for use in paroxysmal supraventricular tachycardia.
  • Sagent had adenosine vials on shortage due to increased demand.
  • West-Ward has adenosine injection on shortage due to manufacturing delays.

Available Products

Diagnostic Adjunct
Adenosine intravenous injection, Akorn
3 mg/mL, 30 mL vial, 1 count (NDC 17478-0544-30)
3 mg/mL, 20 mL vial, 1 count (NDC 17478-0544-20)
 
Adenosine intravenous injection, Hospira
3 mg/mL, 20 mL vial, 25 count (NDC 00409-1932-01)
3 mg/mL, 30 mL vial, 25 count (NDC 00409-1932-02)

Adenosine intravenous injection, Sagent
3 mg/mL, 20 mL vial, 1 count (NDC 25021-0307-20)
3 mg/mL, 30 mL vial, 1 count (NDC 25021-0307-30)

Adenosine intravenous injection, Teva
3 mg/mL, 20 mL vial, 1 count (NDC 00703-8776-01)
3 mg/mL, 30 mL vial, 1 count (NDC 00703-8777-01)
 
Use in Paroxysmal Supraventricular Tachycardia
Adenocard intravenous injection, Astellas
3 mg/mL, 2 mL prefilled syringe, 10 count (NDC 00469-8234-12)
3 mg/mL, 4 mL prefilled syringe, 10 count (NDC 00469-8234-14)
 
Adenosine intravenous injection, Akorn
3 mg/mL, 2 mL vial, 10 count (NDC 17478-0542-02)
3 mg/mL, 2 mL vial, 25 count (NDC 17478-0542-25)
 
Adenosine intravenous injection, Fresenius Kabi
3 mg/mL, 2 mL vial, 10 count (NDC 63323-0651-02)
3 mg/mL, 4 mL vial, 10 count (NDC 63323-0651-04)

Adenosine intravenous injection, Sagent
3 mg/mL, 2 mL prefilled syringe, 10 count (NDC 25021-0301-67)
3 mg/mL, 2 mL vial, 10 count (NDC 25021-0301-02)
3 mg/mL, 4 mL prefilled syringe, 10 count (NDC 25021-0301-68)
3 mg/mL, 4 mL vial, 10 count (NDC 25021-0301-04)

Estimated Resupply Dates

  • West-Ward has adenosine 3 mg/mL 2 mL vials on back order and the company cannot estimate a release date.
  • All other marketed presentations are available.

Related Shortages

Updated

January 29, 2016; November 20, 17 and 4, October 1, September 24, August 26 and 12, July 9, June 25, May 27 and 20, April 27 and 16, March 27, 20, 12, 5 and 4, February 20, January 29, 26 and 9, 2015; December 15, November 17, September 23 and 8, August 4, July 18 and 3, May 22, 15, 13 and 7, April 25, 24 and 1, March 28, 17, 14 and 4, February 21 and 12, January 14, 2014; December 11, October 18, September 16, August 29 and 15, July 18, May 15 and 13, April 11, March 13 and 1, February 13, January 25, 2013; December 28 and 21, November 19, 2012, University of Utah, Drug Information Service. Copyright 2016, Drug Information Service, University of Utah, Salt Lake City, UT.

Disclaimer

This information is provided through the support of Novation to ASHP solely as a service to its members, which shall not use this information for their further commercial use. The content was prepared by the Drug Information Center of University of Utah. Novation, ASHP, and the University of Utah make no representations or warranties, express or implied, including, but not limited to, any implied warranty of merchantability and/or fitness for a particular purpose, which respect to such information, and specifically disclaim all such warranties. Users of this information are advised that decisions regarding the use of drugs and drug therapies are complex medical decisions and that in using this information, each user must exercise his or her own independent professional judgment. Neither Novation, ASHP nor the University of Utah assumes any liability for persons administering or receiving drugs or other medical care in reliance upon this information, or otherwise in connection with this bulletin. Neither Novation, ASHP nor University of Utah endorses or recommends the use of any drug.

« Back to Drug Shortage Product Bulletins

Advocacy Activity
Get the latest updates on ASHP's advocacy activity on drug shortages.
Advertisement
ASHP Product Listing